Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate

Journal of Biochemistry

Volumn 149, Issue 6, 2011, Pages 685-692

  Huang, Chih Hsiang ^a   Suen, Ching Shu ^b   Lin, Ching Ting ^a   Chien, Chia Hui ^a   Lee, Hsin Ying ^a   Chung, Kuei Min ^a   Tsai, Ting Yueh ^a   Jiaang, Weir Tong ^a   Hwang, Ming Jing ^b   Chen, Xin ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

2 anti plasmin; cleavage site specificity; dipeptidyl peptidase; FAP; fibroblast activation protein

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBROBLAST ACTIVATION PROTEIN; GELATIN; GLUTAMIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 8; PEPTIDE LIBRARY; PROLYL ENDOPEPTIDASE; SPROUTY 2 PROTEIN; SPROUTY PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ELECTRICITY; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; IN VITRO STUDY; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE;

CELLS, CULTURED; GELATINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MODELS, MOLECULAR; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY;

EID: 79957846744     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr017     Document Type: Article

References (31)

1. Rosenblum, J.S. and Kozarich, J.W. (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7, 496-504 (Pubitemid 36980841)
2. Scanlan, M.J., Raj, B.K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M.P., Healey, J.H., Old, L.J., and Rettig, W.J. (1994) Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA 91, 5657-5661 (Pubitemid 24174387)
3. Rettig, W.J., Garin-Chesa, P., Beresford, H.R., Oettgen, H.F., Melamed, M.R., and Old, L.J. (1988) Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl. Acad. Sci. USA 85, 3110-3114
4. Huber, M.A., Kraut, N., Park, J.E., Schubert, R.D., Rettig, W.J., Peter, R.U., and Garin-Chesa, P. (2003) Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J. Invest. Dermatol. 120, 182-188 (Pubitemid 36513065)
5. Cheng, J.D., Dunbrack, R.L. Jr, Valianou, M., Rogatko, A., Alpaugh, R.K., and Weiner, L.M. (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 62, 4767-4772
6. Santos, A.M., Jung, J., Aziz, N., Kissil, J.L., and Pure, E. (2009) Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 119, 3613-3625
7. Kraman, M., Bambrough, P.J., Arnold, J.N., Roberts, E.W., Magiera, L., Jones, J.O., Gopinathan, A., Tuveson, D.A., and Fearon, D.T. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330, 827-830
8. Aertgeerts, K., Levin, I., Shi, L., Snell, G.P., Jennings, A., Prasad, G.S., Zhang, Y., Kraus, M.L., Salakian, S., Sridhar, V., Wijnands, R., and Tennant, M.G. (2005) Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J. Biol. Chem. 280, 19441-19444 (Pubitemid 41379462)
9. Park, J.E., Lenter, M.C., Zimmermann, R.N., Garin- Chesa, P., Old, L.J., and Rettig, W.J. (1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274, 36505-36512
10. Aggarwal, S., Brennen, W.N., Kole, T.P., Schneider, E., Topaloglu, O., Yates, M., Cotter, R.J., and Denmeade, S.R. (2008) Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry 47, 1076-1086
11. Christiansen, V.J., Jackson, K.W., Lee, K.N., and McKee, P.A. (2007) Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch. Biochem. Biophys. 457, 177-186 (Pubitemid 46048698)
12. Edosada, C.Y., Quan, C., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J.M., Raab, H., Fairbrother, W., and Wolf, B.B. (2006) Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J. Biol. Chem. 281, 7437-7444 (Pubitemid 43847515)
13. Lee, K.N., Jackson, K.W., Christiansen, V.J., Lee, C.S., Chun, J.G., and McKee, P.A (Pubitemid 43242374)
14. Lee, K.N., Jackson, K.W., Christiansen, V.J., Chung, K.H., and McKee, P.A. (2004) A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood 103, 3783-3788 (Pubitemid 38596296)
15. Edosada, C.Y., Quan, C., Tran, T., Pham, V., Wiesmann, C., Fairbrother, W., and Wolf, B.B. (2006) Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett. 580, 1581-1586 (Pubitemid 43290354)
16. Chien, C.H., Huang, L.H., Chou, C.Y., Chen, Y.S., Han, Y.S., Chang, G.G., Liang, P.H., and Chen, X. (2004) One site mutation disrupts dimer formation in human DPP-IV proteins. J. Biol. Chem. 279, 52338-52345 (Pubitemid 39656609)
17. Lee, H.J., Chen, Y.S., Chou, C.Y., Chien, C.H., Lin, C.H., Chang, G.G., and Chen, X. (2006) Investigation of the dimer interface and substrate specificity of prolyl dipeptidase DPP8. J. Biol. Chem. 281, 38653-38662 (Pubitemid 46041990)
18. Rasmussen, H.B., Branner, S., Wiberg, F.C., and Wagtmann, N. (2003) Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 10, 19-25 (Pubitemid 36034172)
19. Tsai, T.Y., Yeh, T.K., Chen, X., Hsu, T., Jao, Y.C., Huang, C.H., Song, J.S., Huang, Y.C., Chien, C.H., Chiu, J.H., Yen, S.C., Tang, H.K., Chao, Y.S., and Jiaang, W.T. (2010) Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein. J. Med. Chem. 53, 6572-6583
20. Haglund, K., Schmidt, M.H., Wong, E.S., Guy, G.R., and Dikic, I. (2005) Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep. 6, 635-641 (Pubitemid 41122431)
21. Henry, L.R., Lee, H.O., Lee, J.S., Klein-Szanto, A., Watts, P., Ross, E.A., Chen, W.T., and Cheng, J.D. (2007) Clinical implications of fibroblast activation protein in patients with colon cancer. Clin. Cancer Res. 13, 1736-1741 (Pubitemid 46952939)
22. Lee, J., Fassnacht, M., Nair, S., Boczkowski, D., and Gilboa, E. (2005) Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumorassociated fibroblasts. Cancer Res. 65, 11156-11163 (Pubitemid 41713387)
23. Loeffler, M., Kruger, J.A., Niethammer, A.G., and Reisfeld, R.A. (2006) Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 116, 1955-1962 (Pubitemid 44033319)
24. Adams, S., Miller, G.T., Jesson, M.I., Watanabe, T., Jones, B., and Wallner, B.P. (2004) PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 64, 5471-5480 (Pubitemid 39006571)
25. Narra, K., Mullins, S.R., Lee, H.O., Strzemkowski- Brun, B., Magalong, K., Christiansen, V.J., McKee, P.A., Egleston, B., Cohen, S.J., Weiner, L.M., Meropol, N.J., and Cheng, J.D. (2007) Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol. Ther. 6, 1691-1699 (Pubitemid 351590302)
26. Hofheinz, R.D., al-Batran, S.E., Hartmann, F., Hartung, G., Jager, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., and Stehle, G. (2003) Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie 26, 44-48 (Pubitemid 36302438)
27. Lee, K.N., Jackson, K.W., Terzyan, S., Christiansen, V.J., and McKee, P.A. (2009) Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design. Biochemistry 48, 5149-5158
28. Mentlein, R. (1999) Dipeptidyl-peptidase IV (CD26)- role in the inactivation of regulatory peptides. Regul. Pept. 85, 9-24 (Pubitemid 29505281)
29. Kasche, V. (1989) Proteolytic enzymes, a practical approach in A Practical Approach (Beynon, R.J. and Bond, J.S., eds.), pp. 125-143, IRL press, Oxford
30. Keil, B. (1992) Specificity of Proteolysis. Springer, Berlin
31. Thoma, R., Loffler, B., Stihle, M., Huber, W., Ruf, A., and Hennig, M. (2003) Structural basis of prolinespecific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11, 947-959 (Pubitemid 36966784)